Smoking as a risk factor for the radiological severity of rheumatoid arthritis: A study on six cohorts

Annals of the Rheumatic Diseases

Volumn 73, Issue 7, 2014, Pages 1384-1387

  De Rooy, D P C ^a   Van Nies, J A B ^a   Kapetanovic, M C ^b,c   Kristjansdottir, H ^d   Andersson, M L E ^b,e   Forslind, K ^b,f   Van Der Heijde, D M F M ^a   Gregersen, P K ^g   Lindqvist, E ^b,c   Huizinga, T W J ^a   Grondal G ^d   Svensson, B ^b   Van Der Helm Van Mil, A H M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LUND UNIVERSITY   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^e Spenshult Hospital   (Sweden)

^f Section of Rheumatology   (Sweden)

^g Northwell Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY;

ADULT; ARTICLE; COHORT ANALYSIS; DISEASE SEVERITY; FEMALE; FOOT RADIOGRAPHY; HAND RADIOGRAPHY; HUMAN; ICELAND; JOINT DESTRUCTION; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SMOKING; SWEDEN; UNITED STATES;

ANT-CCP; OUTCOMES RESEARCH; RHEUMATOID ARTHRITIS; SMOKING;

ADULT; AGED; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; FOOT JOINTS; HAND JOINTS; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PEPTIDES, CYCLIC; SEVERITY OF ILLNESS INDEX; SMOKING;

EID: 84902298413     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2013-203940     Document Type: Article

References (20)

1. Knevel R, Grondal G, Huizinga TW, et al. Genetic predisposition of the severity of joint destruction in rheumatoid arthritis: A population-based study. Ann Rheum Dis 2012;71:707-9.
2. Sugiyama D, Nishimura K, Tamaki K, et al. Impact of smoking as a risk factor for developing rheumatoid arthritis: A meta-analysis of observational studies. Ann Rheum Dis 2010;69:70-81.
3. Kallberg H, Ding B, Padyukov L, et al. Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke. Ann Rheum Dis 2011;70:508-11.
4. Klareskog L, Stolt P, Lundberg K, et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 2006;54:38-46. (Pubitemid 43122184)
5. Willemze A, van der Woude D, Ghidey W, et al. The interaction between HLA shared epitope alleles and smoking and its contribution to autoimmunity against several citrullinated antigens. Arthritis Rheum 2011;63:1823-32.
6. Forslind K, Ahlmen M, Eberhardt K, et al. Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP). Ann Rheum Dis 2004;63:1090-5. (Pubitemid 39120360)
7. Westhoff G, Rau R, Zink A. Rheumatoid arthritis patients who smoke have a higher need for DMARDs and feel worse, but they do not have more joint damage than non-smokers of the same serological group. Rheumatology (Oxford) 2011;47:849-54. (Pubitemid 351796371)
8. Manfredsdottir VF, Vikingsdottir T, Jonsson T, et al. The effects of tobacco smoking and rheumatoid factor seropositivity on disease activity and joint damage in early rheumatoid arthritis. Rheumatology (Oxford) 2006;45: 734-40. (Pubitemid 43985343)
9. Finckh A, Dehler S, Costenbader KH, et al. Cigarette smoking and radiographic progression in rheumatoid arthritis. Ann Rheum Dis 2007;66:1066-71. (Pubitemid 47122321)
10. Wolfe F, Zwillich SH. The long-term outcomes of rheumatoid arthritis: A 23-year prospective, longitudinal study of total joint replacement and its predictors in 1, 600 patients with rheumatoid arthritis. Arthritis Rheum 1998;41:1072-82. (Pubitemid 28265410)
11. de Rooy DP, van der Linden MP, Knevel R, et al. Predicting arthritis outcomes- what can be learned from the Leiden Early Arthritis Clinic? Rheumatology (Oxford) 2011;50:93-100.
12. van der Heijde D, Boers M, Lassere M. Methodological issues in radiographic scoring methods in rheumatoid arthritis. J Rheumatol 1999;26:726-30. (Pubitemid 29125600)
13. Svensson B, Boonen A, Albertsson K, et al. Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: A two-year randomized trial. Arthritis Rheum 1995;52:3360-70.
14. Choi HK, Hernan MA, Seeger JD, et al. Methotrexate and mortality in patients with rheumatoid arthritis: A prospective study. Lancet 2002;359:1173-7. (Pubitemid 34304256)
15. Wolfe F, Michaud K. The National Data Bank for rheumatic diseases: A multi-registry rheumatic disease data bank. Rheumatology (Oxford) 2011;50:16-24.
16. Finckh A, Choi HK, Wolfe F. Progression of radiographic joint damage in different eras: Trends towards milder disease in rheumatoid arthritis are attributable to improved treatment. Ann Rheum Dis 2006;65:1192-7. (Pubitemid 44277395)
17. Fex E, Jonsson K, Johnson U, et al. Development of radiographic damage during the first 5-6 yr of rheumatoid arthritis. A prospective follow-up study of a Swedish cohort. Br J Rheumatol 1996;35:1106-15.
18. Lindqvist E, Jonsson K, Saxne T, et al. Course of radiographic damage over 10 years in a cohort with early rheumatoid arthritis. Ann Rheum Dis 2003;62:611-16. (Pubitemid 36760556)
19. Larsen A, Dale K, Eek M. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn (Stockh) 1977;18:481-91. (Pubitemid 8198049)
20. Knevel R, Tsonaka R, le Cessie, et al. Comparison of methodologies for analysing the progression of joint destruction in rheumatoid arthritis. Scand J Rheumatol 2013;42:182-9.